Participation of NIAAA in PA-09-111 (R01) and PA-09-112 (R21) Developmental Psychopharmacology

Notice Number: NOT-AA-09-002

Key Dates
Release Date: March 12, 2009

Issued by
National Institute on Alcohol Abuse and Alcoholism (NIAAA), (


This Notice announces the participation of the NATIONAL INSTITUTE OF ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) in PA-09-111 entitled Developmental Psychopharmacology (R01) and PA-09-112 entitled Developmental Psychopharmacology (R21).

NIAAA Statement of Interest: The NIAAA is interested in the possible impact of psychopharmacological medications on neurobehavioral development in children and adolescents diagnosed with Fetal Alcohol Syndrome (FAS) or a Fetal Alcohol Spectrum Disorder (FASD). Responsive studies may include research on the mechanisms of drug action during developmental change and studies on the effects of psychopharmacological medications on cognitive and behavioral development, neural development, and physical growth. Studies are also encouraged that investigate if these medications may confer a protective factor or vulnerability for abuse especially during adolescence or may contribute to addiction later in life as result of treatment within the developmental period.

The following ICs continue to Participate in this FOA:

National Institute of Mental Health (NIMH), (
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), (
National Institute on Drug Abuse (NIDA), (

All other aspects of these Program Announcements remain unchanged.


Inquiries and discussion of plans for responding to this Notice are strongly encouraged.

Program Contact:

John A. Matochik, Ph.D.
Division of Neuroscience & Behavior
National Institute on Alcohol Abuse and Alcoholism
5635 Fishers Lane, Room 2048, MSC 9304
Bethesda, MD 20892-9304
Telephone: (301) 451-7319
FAX: (301) 443-1650

Grants Management Contact:

Judy Fox
Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, DHHS
5635 Fishers Lane, Room 3023, MSC 9304
Bethesda, MD 20892-9304
[For express mail use: Rockville, MD 20852-1705]
Telephone: 301-443-4704
FAX: 301-443-3891